The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Oligosaccharide for Infant Formula Market Research Report 2024
Synopsis
Oligosaccharides for infant formula refer to a group of carbohydrates that are added to infant formula to mimic the naturally occurring oligosaccharides found in human breast milk. Oligosaccharides are composed of a small number of sugar molecules linked together, typically ranging from two to ten sugar units.
Global Oligosaccharide for Infant Formula market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oligosaccharide for Infant Formula market research.
Human breast milk contains a variety of oligosaccharides that play important roles in promoting the growth of beneficial bacteria in the baby's gut and supporting overall gut health. However, these oligosaccharides are not present in standard cow's milk-based infant formulas. To bridge this gap, oligosaccharides derived from either human milk or other sources, such as plants, are added to infant formula.
The most commonly used oligosaccharides in infant formula include galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS). These oligosaccharides are structurally similar to the ones found in human breast milk and serve as a food source for beneficial bacteria (probiotics) in the baby's gut. By promoting the growth of these beneficial bacteria, oligosaccharides help establish a healthy gut microbiota and support various aspects of infant health and development.
Adding oligosaccharides to infant formula offers several potential benefits. They can contribute to the development of a balanced and diverse gut microbiome, which may support the baby's immune system, aid in digestion, and potentially reduce the risk of certain health conditions, such as allergies and infections. Additionally, oligosaccharides in infant formula may have prebiotic effects, which means they selectively stimulate the growth and activity of beneficial bacteria while inhibiting the growth of harmful bacteria.
It's important to note that oligosaccharides in infant formula should not be confused with prebiotics or probiotics. While oligosaccharides serve as prebiotics, providing nourishment for probiotics, probiotics themselves are live bacteria or yeasts that can provide direct health benefits when consumed.
Human breast milk contains a variety of oligosaccharides that play important roles in promoting the growth of beneficial bacteria in the baby's gut and supporting overall gut health. However, these oligosaccharides are not present in standard cow's milk-based infant formulas. To bridge this gap, oligosaccharides derived from either human milk or other sources, such as plants, are added to infant formula.
The most commonly used oligosaccharides in infant formula include galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS). These oligosaccharides are structurally similar to the ones found in human breast milk and serve as a food source for beneficial bacteria (probiotics) in the baby's gut. By promoting the growth of these beneficial bacteria, oligosaccharides help establish a healthy gut microbiota and support various aspects of infant health and development.
Adding oligosaccharides to infant formula offers several potential benefits. They can contribute to the development of a balanced and diverse gut microbiome, which may support the baby's immune system, aid in digestion, and potentially reduce the risk of certain health conditions, such as allergies and infections. Additionally, oligosaccharides in infant formula may have prebiotic effects, which means they selectively stimulate the growth and activity of beneficial bacteria while inhibiting the growth of harmful bacteria.
It's important to note that oligosaccharides in infant formula should not be confused with prebiotics or probiotics. While oligosaccharides serve as prebiotics, providing nourishment for probiotics, probiotics themselves are live bacteria or yeasts that can provide direct health benefits when consumed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oligosaccharide for Infant Formula market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
FrieslandCampina
Meiji
Yakult
Baolingbao
Beneo-Orafti
Bailong
Ingredion
Sensus
QHT
Nikon Shikuhin KaKo
Nissin-sugar
Cosucra
Segment by Type
Fructooligosaccharide
Galactooligosaccharides
Human Milk Oligosaccharides
Segment by Application
Standard
Follow on
Toddler
Specialty
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Oligosaccharide for Infant Formula report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Oligosaccharides for infant formula refer to a group of carbohydrates that are added to infant formula to mimic the naturally occurring oligosaccharides found in human breast milk. Oligosaccharides are composed of a small number of sugar molecules linked together, typically ranging from two to ten sugar units.
Global Oligosaccharide for Infant Formula market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oligosaccharide for Infant Formula market research.
Human breast milk contains a variety of oligosaccharides that play important roles in promoting the growth of beneficial bacteria in the baby's gut and supporting overall gut health. However, these oligosaccharides are not present in standard cow's milk-based infant formulas. To bridge this gap, oligosaccharides derived from either human milk or other sources, such as plants, are added to infant formula.
The most commonly used oligosaccharides in infant formula include galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS). These oligosaccharides are structurally similar to the ones found in human breast milk and serve as a food source for beneficial bacteria (probiotics) in the baby's gut. By promoting the growth of these beneficial bacteria, oligosaccharides help establish a healthy gut microbiota and support various aspects of infant health and development.
Adding oligosaccharides to infant formula offers several potential benefits. They can contribute to the development of a balanced and diverse gut microbiome, which may support the baby's immune system, aid in digestion, and potentially reduce the risk of certain health conditions, such as allergies and infections. Additionally, oligosaccharides in infant formula may have prebiotic effects, which means they selectively stimulate the growth and activity of beneficial bacteria while inhibiting the growth of harmful bacteria.
It's important to note that oligosaccharides in infant formula should not be confused with prebiotics or probiotics. While oligosaccharides serve as prebiotics, providing nourishment for probiotics, probiotics themselves are live bacteria or yeasts that can provide direct health benefits when consumed.
Human breast milk contains a variety of oligosaccharides that play important roles in promoting the growth of beneficial bacteria in the baby's gut and supporting overall gut health. However, these oligosaccharides are not present in standard cow's milk-based infant formulas. To bridge this gap, oligosaccharides derived from either human milk or other sources, such as plants, are added to infant formula.
The most commonly used oligosaccharides in infant formula include galacto-oligosaccharides (GOS) and fructo-oligosaccharides (FOS). These oligosaccharides are structurally similar to the ones found in human breast milk and serve as a food source for beneficial bacteria (probiotics) in the baby's gut. By promoting the growth of these beneficial bacteria, oligosaccharides help establish a healthy gut microbiota and support various aspects of infant health and development.
Adding oligosaccharides to infant formula offers several potential benefits. They can contribute to the development of a balanced and diverse gut microbiome, which may support the baby's immune system, aid in digestion, and potentially reduce the risk of certain health conditions, such as allergies and infections. Additionally, oligosaccharides in infant formula may have prebiotic effects, which means they selectively stimulate the growth and activity of beneficial bacteria while inhibiting the growth of harmful bacteria.
It's important to note that oligosaccharides in infant formula should not be confused with prebiotics or probiotics. While oligosaccharides serve as prebiotics, providing nourishment for probiotics, probiotics themselves are live bacteria or yeasts that can provide direct health benefits when consumed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oligosaccharide for Infant Formula market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
FrieslandCampina
Meiji
Yakult
Baolingbao
Beneo-Orafti
Bailong
Ingredion
Sensus
QHT
Nikon Shikuhin KaKo
Nissin-sugar
Cosucra
Segment by Type
Fructooligosaccharide
Galactooligosaccharides
Human Milk Oligosaccharides
Segment by Application
Standard
Follow on
Toddler
Specialty
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Oligosaccharide for Infant Formula report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Index1 Oligosaccharide for Infant Formula Market Overview
1.1 Product Definition
1.2 Oligosaccharide for Infant Formula Segment by Type
1.2.1 Global Oligosaccharide for Infant Formula Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Fructooligosaccharide
1.2.3 Galactooligosaccharides
1.2.4 Human Milk Oligosaccharides
1.3 Oligosaccharide for Infant Formula Segment by Application
1.3.1 Global Oligosaccharide for Infant Formula Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Standard
1.3.3 Follow on
1.3.4 Toddler
1.3.5 Specialty
1.4 Global Market Growth Prospects
1.4.1 Global Oligosaccharide for Infant Formula Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Oligosaccharide for Infant Formula Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Oligosaccharide for Infant Formula Production Estimates and Forecasts (2018-2029)
1.4.4 Global Oligosaccharide for Infant Formula Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Oligosaccharide for Infant Formula Production Market Share by Manufacturers (2018-2023)
2.2 Global Oligosaccharide for Infant Formula Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Oligosaccharide for Infant Formula, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Oligosaccharide for Infant Formula Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Oligosaccharide for Infant Formula Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Oligosaccharide for Infant Formula, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Oligosaccharide for Infant Formula, Product Offered and Application
2.8 Global Key Manufacturers of Oligosaccharide for Infant Formula, Date of Enter into This Industry
2.9 Oligosaccharide for Infant Formula Market Competitive Situation and Trends
2.9.1 Oligosaccharide for Infant Formula Market Concentration Rate
2.9.2 Global 5 and 10 Largest Oligosaccharide for Infant Formula Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Oligosaccharide for Infant Formula Production by Region
3.1 Global Oligosaccharide for Infant Formula Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Oligosaccharide for Infant Formula Production Value by Region (2018-2029)
3.2.1 Global Oligosaccharide for Infant Formula Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Oligosaccharide for Infant Formula by Region (2024-2029)
3.3 Global Oligosaccharide for Infant Formula Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Oligosaccharide for Infant Formula Production by Region (2018-2029)
3.4.1 Global Oligosaccharide for Infant Formula Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Oligosaccharide for Infant Formula by Region (2024-2029)
3.5 Global Oligosaccharide for Infant Formula Market Price Analysis by Region (2018-2023)
3.6 Global Oligosaccharide for Infant Formula Production and Value, Year-over-Year Growth
3.6.1 North America Oligosaccharide for Infant Formula Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Oligosaccharide for Infant Formula Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Oligosaccharide for Infant Formula Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Oligosaccharide for Infant Formula Production Value Estimates and Forecasts (2018-2029)
4 Oligosaccharide for Infant Formula Consumption by Region
4.1 Global Oligosaccharide for Infant Formula Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Oligosaccharide for Infant Formula Consumption by Region (2018-2029)
4.2.1 Global Oligosaccharide for Infant Formula Consumption by Region (2018-2023)
4.2.2 Global Oligosaccharide for Infant Formula Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Oligosaccharide for Infant Formula Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Oligosaccharide for Infant Formula Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Oligosaccharide for Infant Formula Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Oligosaccharide for Infant Formula Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Oligosaccharide for Infant Formula Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Oligosaccharide for Infant Formula Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Oligosaccharide for Infant Formula Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Oligosaccharide for Infant Formula Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Oligosaccharide for Infant Formula Production by Type (2018-2029)
5.1.1 Global Oligosaccharide for Infant Formula Production by Type (2018-2023)
5.1.2 Global Oligosaccharide for Infant Formula Production by Type (2024-2029)
5.1.3 Global Oligosaccharide for Infant Formula Production Market Share by Type (2018-2029)
5.2 Global Oligosaccharide for Infant Formula Production Value by Type (2018-2029)
5.2.1 Global Oligosaccharide for Infant Formula Production Value by Type (2018-2023)
5.2.2 Global Oligosaccharide for Infant Formula Production Value by Type (2024-2029)
5.2.3 Global Oligosaccharide for Infant Formula Production Value Market Share by Type (2018-2029)
5.3 Global Oligosaccharide for Infant Formula Price by Type (2018-2029)
6 Segment by Application
6.1 Global Oligosaccharide for Infant Formula Production by Application (2018-2029)
6.1.1 Global Oligosaccharide for Infant Formula Production by Application (2018-2023)
6.1.2 Global Oligosaccharide for Infant Formula Production by Application (2024-2029)
6.1.3 Global Oligosaccharide for Infant Formula Production Market Share by Application (2018-2029)
6.2 Global Oligosaccharide for Infant Formula Production Value by Application (2018-2029)
6.2.1 Global Oligosaccharide for Infant Formula Production Value by Application (2018-2023)
6.2.2 Global Oligosaccharide for Infant Formula Production Value by Application (2024-2029)
6.2.3 Global Oligosaccharide for Infant Formula Production Value Market Share by Application (2018-2029)
6.3 Global Oligosaccharide for Infant Formula Price by Application (2018-2029)
7 Key Companies Profiled
7.1 FrieslandCampina
7.1.1 FrieslandCampina Oligosaccharide for Infant Formula Corporation Information
7.1.2 FrieslandCampina Oligosaccharide for Infant Formula Product Portfolio
7.1.3 FrieslandCampina Oligosaccharide for Infant Formula Production, Value, Price and Gross Margin (2018-2023)
7.1.4 FrieslandCampina Main Business and Markets Served
7.1.5 FrieslandCampina Recent Developments/Updates
7.2 Meiji
7.2.1 Meiji Oligosaccharide for Infant Formula Corporation Information
7.2.2 Meiji Oligosaccharide for Infant Formula Product Portfolio
7.2.3 Meiji Oligosaccharide for Infant Formula Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Meiji Main Business and Markets Served
7.2.5 Meiji Recent Developments/Updates
7.3 Yakult
7.3.1 Yakult Oligosaccharide for Infant Formula Corporation Information
7.3.2 Yakult Oligosaccharide for Infant Formula Product Portfolio
7.3.3 Yakult Oligosaccharide for Infant Formula Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Yakult Main Business and Markets Served
7.3.5 Yakult Recent Developments/Updates
7.4 Baolingbao
7.4.1 Baolingbao Oligosaccharide for Infant Formula Corporation Information
7.4.2 Baolingbao Oligosaccharide for Infant Formula Product Portfolio
7.4.3 Baolingbao Oligosaccharide for Infant Formula Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Baolingbao Main Business and Markets Served
7.4.5 Baolingbao Recent Developments/Updates
7.5 Beneo-Orafti
7.5.1 Beneo-Orafti Oligosaccharide for Infant Formula Corporation Information
7.5.2 Beneo-Orafti Oligosaccharide for Infant Formula Product Portfolio
7.5.3 Beneo-Orafti Oligosaccharide for Infant Formula Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Beneo-Orafti Main Business and Markets Served
7.5.5 Beneo-Orafti Recent Developments/Updates
7.6 Bailong
7.6.1 Bailong Oligosaccharide for Infant Formula Corporation Information
7.6.2 Bailong Oligosaccharide for Infant Formula Product Portfolio
7.6.3 Bailong Oligosaccharide for Infant Formula Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Bailong Main Business and Markets Served
7.6.5 Bailong Recent Developments/Updates
7.7 Ingredion
7.7.1 Ingredion Oligosaccharide for Infant Formula Corporation Information
7.7.2 Ingredion Oligosaccharide for Infant Formula Product Portfolio
7.7.3 Ingredion Oligosaccharide for Infant Formula Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Ingredion Main Business and Markets Served
7.7.5 Ingredion Recent Developments/Updates
7.8 Sensus
7.8.1 Sensus Oligosaccharide for Infant Formula Corporation Information
7.8.2 Sensus Oligosaccharide for Infant Formula Product Portfolio
7.8.3 Sensus Oligosaccharide for Infant Formula Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Sensus Main Business and Markets Served
7.7.5 Sensus Recent Developments/Updates
7.9 QHT
7.9.1 QHT Oligosaccharide for Infant Formula Corporation Information
7.9.2 QHT Oligosaccharide for Infant Formula Product Portfolio
7.9.3 QHT Oligosaccharide for Infant Formula Production, Value, Price and Gross Margin (2018-2023)
7.9.4 QHT Main Business and Markets Served
7.9.5 QHT Recent Developments/Updates
7.10 Nikon Shikuhin KaKo
7.10.1 Nikon Shikuhin KaKo Oligosaccharide for Infant Formula Corporation Information
7.10.2 Nikon Shikuhin KaKo Oligosaccharide for Infant Formula Product Portfolio
7.10.3 Nikon Shikuhin KaKo Oligosaccharide for Infant Formula Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Nikon Shikuhin KaKo Main Business and Markets Served
7.10.5 Nikon Shikuhin KaKo Recent Developments/Updates
7.11 Nissin-sugar
7.11.1 Nissin-sugar Oligosaccharide for Infant Formula Corporation Information
7.11.2 Nissin-sugar Oligosaccharide for Infant Formula Product Portfolio
7.11.3 Nissin-sugar Oligosaccharide for Infant Formula Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Nissin-sugar Main Business and Markets Served
7.11.5 Nissin-sugar Recent Developments/Updates
7.12 Cosucra
7.12.1 Cosucra Oligosaccharide for Infant Formula Corporation Information
7.12.2 Cosucra Oligosaccharide for Infant Formula Product Portfolio
7.12.3 Cosucra Oligosaccharide for Infant Formula Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Cosucra Main Business and Markets Served
7.12.5 Cosucra Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Oligosaccharide for Infant Formula Industry Chain Analysis
8.2 Oligosaccharide for Infant Formula Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Oligosaccharide for Infant Formula Production Mode & Process
8.4 Oligosaccharide for Infant Formula Sales and Marketing
8.4.1 Oligosaccharide for Infant Formula Sales Channels
8.4.2 Oligosaccharide for Infant Formula Distributors
8.5 Oligosaccharide for Infant Formula Customers
9 Oligosaccharide for Infant Formula Market Dynamics
9.1 Oligosaccharide for Infant Formula Industry Trends
9.2 Oligosaccharide for Infant Formula Market Drivers
9.3 Oligosaccharide for Infant Formula Market Challenges
9.4 Oligosaccharide for Infant Formula Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
